Understanding the Landmark Findings from the Singapore Podiatry Study
The recent publication in the Journal of the American Podiatric Medical Association has captured global attention with its striking revelation: podiatric care is linked to a 69% reduction in mortality odds for patients with diabetic foot ulcers (DFUs). This longitudinal analysis from Singapore's Diabetic Foot in Primary and Tertiary (DEFINITE) Care program examined 2,798 patients, comparing those who received podiatric follow-up against those who did not. Despite the podiatry group starting with more severe conditions—higher HbA1c levels, greater prevalence of chronic kidney disease, and prior foot ulcers—the adjusted odds ratio (OR) for death was 0.314 (95% CI 0.239–0.413), translating to substantially better survival prospects.
Lower extremity amputation (LEA)-free survival also improved by 26% (OR 1.26; 95% CI 1.05–1.52), underscoring podiatry's role in not just saving limbs but preserving lives. While minor LEAs were more common (OR 2.01), major LEAs showed a non-significant downward trend, suggesting proactive minor interventions prevent catastrophic outcomes.
This study arrives at a critical juncture for Singapore, where diabetes affects nearly 15% of adults—double the global average—and contributes to disproportionately high amputation rates.
The Burden of Diabetic Foot Ulcers in Singapore
Diabetic foot ulcers represent a devastating complication of diabetes mellitus (DM), a chronic condition characterized by elevated blood glucose levels due to insulin deficiency or resistance. In Singapore, with a population of about 6 million, diabetes prevalence stands at around 422,000 cases as of recent estimates, projected to rise amid aging demographics and lifestyle factors. DFUs occur in up to 25% of DM patients lifetime, often triggered by neuropathy (nerve damage causing loss of sensation), peripheral artery disease (poor blood flow), and infection.
National data reveals Singapore's amputation rates remain elevated compared to peers: age-standardized major LEA rates hovered around 13.3 per 100,000 in earlier audits, with DFU patients facing a 37.9% five-year mortality—exceeding many cancers. Minor amputations (toe/ray) comprise 89% of cases, yet progression to major LEA (below-knee/above-knee) carries 50-70% five-year mortality. The economic toll is immense, with per-patient costs exceeding SGD 20,000 annually, straining the healthcare system.
Singapore's multi-ethnic population—Chinese, Malay, Indian—shows ethnic disparities: Malays and Indians face higher DFU risks due to genetic predispositions and socioeconomic factors. The War on Diabetes initiative aims to halve new cases by 2025, but DFU management lags, highlighting the need for specialized care like podiatry.
Inside the DEFINITE Care Program: A Multidisciplinary Approach
Launched in June 2020 within the National Healthcare Group (NHG)—Singapore's largest public healthcare cluster—DEFINITE Care bridges primary polyclinics and tertiary hospitals like Tan Tock Seng Hospital (TTSH) and Khoo Teck Puat Hospital (KTPH). It follows the DM Foot Screening and Surveillance, Treatment and Escalation Protocol (DM STEP), standardizing risk assessment via the Site, Ischemia, Neuropathy, Bacterial infection, and Area/Depth (SINBAD) classification.
Patients (aged 21+) with active DFUs are enrolled, receiving multidisciplinary input: endocrinologists for glycemic control, vascular surgeons for revascularization, infectious disease specialists for antibiotics, and podiatrists for debridement, offloading, and wound care. Podiatric referral is case-based, prioritizing high-risk cases. By June 2022, 4,274 patients enrolled, with 65.5% achieving 12-month follow-up.
- Risk stratification: Low-risk annual screening; high-risk quarterly podiatry.
- Offloading: Total contact casts or irremovable devices.
- Education: Patient foot care hygiene, shoe fitting.
Prior DEFINITE audits showed 40% mortality reduction and cost savings, setting stage for this podiatry-specific analysis.
Study Design and Patient Characteristics
This retrospective observational study analyzed electronic health records from NHG's registry, adhering to STROBE guidelines. Inclusion required 12-month follow-up post-enrollment; exclusions were incomplete data. Covariates adjusted: age (mean 65.7 years), sex, ethnicity, comorbidities (e.g., 46.3% retinopathy in podiatry group vs 30.5%), medications, prior LEA.
Podiatry cohort (n=1,212) was sicker: poorer control (HbA1c 8.19% vs 7.95%), more end-stage renal disease (19.5% vs 15.3%). Statistical models: logistic regression for binary outcomes (death, LEA-free survival); zero-inflated negative binomial for utilization (admissions, length of stay—LOS).
| Characteristic | Podiatry (n=1212) | No Podiatry (n=1586) |
|---|---|---|
| Age (mean) | 65.2 | 66.1 |
| Malay/Indian (%) | Higher | Lower |
| CKD/ESRF (%) | 19.5 | 15.3 |
| Prior Ulcer (%) | 70.9 | 55.1 |
Breakdown of Clinical Outcomes
Mortality plunged: 399 deaths overall, but podiatry slashed odds by 69%. This aligns with global evidence where DFU signals systemic vulnerability—heart failure, sepsis—but podiatry mitigates via infection control and mobility preservation.
LEA-free survival gained 26%, with 317 minor LEAs (doubled in podiatry, proactive) vs 161 major (trending down). Minor amps preserve function, avoiding wheelchair dependence and secondary mortality.
Process: Podiatrists perform sharp debridement (necrotic tissue removal), biomechanics assessment (pressure redistribution via custom insoles), and surveillance, preventing ulcer recurrence (65% within 3-5 years untreated).
Full study details in the Journal of the American Podiatric Medical Association.
Photo by Tanya Barrow on Unsplash
Healthcare Resource Utilization: Short-Term Costs, Long-Term Gains
Podiatry increased utilization: 28% more admissions (IRR 1.28), 61% more day surgeries, 24% more ED visits, 51% more outpatient visits—reflecting intensive management. Yet LOS shortened 17% (IRR 0.833), curbing costs (SGD 1,000+ daily inpatient).
No primary care visit difference. Cost-effectiveness mirrors prior: early intervention averts expensive major amps (SGD 50,000+ lifetime).
The Podiatrist's Role: Step-by-Step Impact Explained
Podiatry (study of foot/ankle disorders; Doctor of Podiatric Medicine or equivalent) integrates:
- Assessment: Neuropathy testing (monofilament), vascular Doppler, ulcer grading (Wagner/SINBAD).
- Debridement: Removes biofilm, promotes granulation.
- Offloading: Felted foam, rocker shoes reduce peak pressure 50%.
- Wound care: Advanced dressings (hydrofibers, NPWT).
- Adjuncts: Refer vascular/endocrine, patient education.
In Asia, cultural barefoot habits exacerbate risks; podiatry addresses via custom orthotics.
Addressing Singapore's Podiatry Shortage
With ~100 podiatrists for 6 million (1:60,000 ratio vs UK's 1:20,000), access is limited. No undergraduate podiatry degree locally—trainees pursue diplomas at polytechnics (e.g., Ngee Ann's biomedical) then overseas bachelor's (Australia's La Trobe, UK's Huddersfield).
Study spotlights crisis: sicker patients prioritized, yet outcomes superior. Solution: Expand training, perhaps university degrees at NUS/NTU allied health faculties, incentivize returns.
Association of Podiatric Medicine Singapore on training paths.Stakeholder Perspectives and Expert Insights
Lead author Wen Zhe Leo (vascular surgeon, Woodlands Health) notes: "Podiatry not just wound care—systemic lifesaver." Q&A highlights: early minor amps preferable; Asian data scarce, filling gap.
David Armstrong (USC, limb salvage expert): "Game-changer for Asia's diabetes tsunami." Policymakers eye scaling DEFINITE nationally via Health Promotion Board.
Implications for Higher Education and Training
Singapore's polytechnics (NYP, NP) offer health sciences diplomas, but podiatry demands bachelor's+. Universities like NTU (biomed eng) collaborate on research, yet no dedicated program. Study advocates curriculum integration: podiatry modules in nursing/medicine degrees, PhD tracks in diabetic foot biomechanics.
Global models: Australia's uni podiatry grads fill gaps. Singapore could pioneer Asia's first BSc Podiatry, boosting 200+ workforce by 2030.
Photo by Julian Kraus on Unsplash
Future Directions and Policy Recommendations
Longer-term RCTs needed; cost-benefit analyses (ICER under SGD 10,000/QALY projected). Integrate tele-podiatry for rural access. National podiatry registry akin to US.
Outlook: With RIE2030 funding research, podiatry could halve Singapore's 3x global amp rate by 2030.
Actionable Insights for Patients, Providers, and Policymakers
- Patients: Daily foot checks, proper footwear, HbA1c <7%.
- Clinics: Routine podiatry referral for DFU.
- Govt: Fund training, 50 new podiatrists/year.
- Researchers: Multi-center Asian trials.
This study redefines podiatry: from niche to essential, saving lives one step at a time.
